— Know what they know.
Not Investment Advice

TPL vs EXE vs PR

161 measures in 16 categories, one definition each, computed from filings and market data.
TPL80.8
Texas Pacific Land Corporation
Energy · Oil & Gas Exploration & Production
$350.92 +1.30%$24.2B mkt cap
Score DNA
EXE77.4
Expand Energy Corporation
Energy · Oil & Gas Exploration & Production
$93.41 +2.87%$21.6B mkt cap
Score DNA
PR76.4
Permian Resources Corporation
Energy · Oil & Gas Exploration & Production
$24.59 +4.28%$20.6B mkt cap
Score DNA

Price, rebased to 100 three years ago

TPL   EXE   PR   · weekly adjusted closes
50100150200250300Jan 24Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26Oct 26PR 183EXE 112TPL 58
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.

Smart money

8 measures
MeasureTPLEXEPR
Insider open-market buys, 180d 113 4 0
Insider $ bought, 180d $0.05M $0.56M —
Congress purchases, 180d 0 0 0
Last Congress purchase — — —
13F net change in holders +14 −46 0
ETFs adding shares, 30d 767 869 354
ETFs trimming, 30d 494 782 254
Net ETF funds, 30d +273 +87 +100

Valuation

16 measures
MeasureTPLEXEPR
P/E (TTM) 44.7x
94th
7.8x
18th
16.7x
71st
PEG (P/E ÷ 3-yr EPS CAGR) — — 9.76
Price / sales 27.0x
98th
1.6x
30th
3.6x
83rd
Price / book 14.5x
98th
1.1x
22nd
1.7x
70th
Price / tangible book 36.8x
100th
1.1x
37th
1.3x
50th
Price / free cash flow 46.0x
97th
8.5x
30th
5.2x
11th
Price / operating cash flow 40.1x
98th
3.8x
39th
5.2x
57th
Enterprise value $24.0B
83rd
$24.0B
85th
$23.6B
81st
EV / sales 26.7x
98th
1.8x
13th
4.1x
83rd
EV / EBITDA 32.1x
95th
3.6x
11th
6.4x
57th
EV / EBIT 35.3x
88th
6.5x
15th
14.5x
76th
EV / free cash flow 45.5x
95th
9.4x
24th
6.0x
11th
Earnings yield 2.2%
32nd
12.9%
87th
6.0%
49th
FCF yield 2.2%
23rd
11.8%
77th
19.1%
91st
Operating cash flow yield 2.5%
4th
26.1%
62nd
19.4%
45th
Graham number (per share) $65.38
68th
$146.21
91st
$21.35
21st

Profitability (TTM)

12 measures
MeasureTPLEXEPR
Gross margin 85.8%
98th
63.1%
81st
49.9%
57th
EBITDA margin 83.1%
100th
49.6%
55th
64.7%
72nd
Operating margin 74.9%
100th
26.0%
53rd
37.7%
74th
EBIT margin 75.6%
100th
27.7%
53rd
28.4%
60th
Net margin 60.3%
100th
20.8%
64th
21.5%
66th
NOPAT margin 59.3%
96th
20.4%
51st
29.6%
66th
FCF margin 58.7%
91st
19.0%
49th
68.7%
96th
Operating cash flow margin 67.2%
89th
42.2%
30th
69.6%
96th
R&D / revenue 0.0%
0th
0.0%
0th
0.0%
0th
SG&A / revenue 0.8%
0th
17.9%
91st
3.2%
13th
Stock comp / revenue 1.9%
81st
0.3%
26th
1.2%
64th
Effective tax rate 20.9%
35th
21.3%
67th
21.5%
70th

Returns on capital

11 measures
MeasureTPLEXEPR
ROE (on average equity) 36.6%
98th
14.9%
57th
11.5%
37th
ROA 33.2%
100th
10.0%
77th
6.9%
47th
ROIC 37.0%
94th
12.6%
62nd
11.3%
53rd
ROCE 38.4%
100th
14.8%
74th
9.9%
51st
Return on tangible assets 41.6%
100th
13.3%
70th
9.1%
45th
Cash ROIC (OCF / invested capital) 41.9%
87th
25.9%
53rd
26.6%
57th
Gross profitability (GP / assets) 46.9%
100th
30.1%
94th
15.5%
47th
ROIC, 3-yr average 36.3%
98th
5.6%
32nd
7.9%
45th
ROIC, 5-yr average 57.6%
97th
21.1%
67th
9.8%
33rd
ROE, 5-yr average 42.2%
90th
21.3%
51st
11.8%
31st
Incremental ROIC 41.8%
63rd
— 52.3%
67th

Growth

17 measures
MeasureTPLEXEPR
Revenue growth (TTM YoY) 20.8%
67th
56.8%
91st
12.8%
41st
Revenue growth (QoQ) 3.9%
28th
-32.7%
9th
33.9%
66th
Revenue CAGR, 3 yr 11.3%
67th
4.4%
52nd
31.0%
93rd
Revenue CAGR, 5 yr 22.2%
59th
44.0%
87th
51.4%
92nd
Gross profit CAGR, 3 yr 12.7%
76th
6.6%
69th
24.1%
86th
Operating income CAGR, 3 yr 9.5%
88th
-14.6%
49th
29.8%
95th
Net income growth (TTM YoY) 17.3%
42nd
1,250.0%
100th
8.4%
26th
Net income CAGR, 3 yr 9.1%
93rd
-23.6%
21st
36.7%
100th
EPS growth (TTM YoY) 17.3%
42nd
1,262.5%
100th
-5.5%
23rd
EPS CAGR, 3 yr -24.3%
31st
-35.5%
7th
1.7%
97th
EPS CAGR, 5 yr -1.6%
15th
-26.3%
0th
—
FCF growth (TTM YoY) 7.6%
30th
118.4%
73rd
1,291.6%
97th
FCF CAGR, 3 yr 6.8%
57th
14.9%
70th
110.0%
100th
Operating cash flow CAGR, 3 yr 10.2%
67th
14.4%
79th
30.3%
93rd
Book value CAGR, 3 yr -14.3%
7th
3.9%
34th
14.3%
73rd
Dividend CAGR, 3 yr -47.8%
0th
-2.2%
59th
-23.6%
12th
Sustainable growth rate 26.0%
91st
10.8%
44th
6.8%
29th

Margin history & stability

7 measures
MeasureTPLEXEPR
Gross margin, 3-yr average 92.7%
100th
48.1%
55th
48.5%
57th
Operating margin, 3-yr average 76.6%
100th
14.2%
16th
35.3%
68th
Net margin, 3-yr average 63.1%
98th
10.7%
36th
19.8%
61st
FCF margin, 3-yr average 63.7%
98th
12.3%
43rd
29.6%
89th
Revenue stability (0-1) 0.95
84th
0.49
39th
0.98
95th
Earnings stability (0-1) 0.85
93rd
0.22
59th
0.94
98th
Margin stability (0-1) 0.97
98th
0.39
0th
0.80
52nd

Liquidity (latest quarter)

7 measures
MeasureTPLEXEPR
Cash & short-term investments $248.6M
64th
$1.4B
91st
$131.7M
55th
Net cash (− = net debt) $233.1M
100th
−$2.4B
40th
−$3.0B
32nd
Working capital $334.3M
87th
−$123.0M
43rd
−$738.2M
9th
Current ratio 4.55
94th
0.96
53rd
0.62
26th
Quick ratio 4.55
94th
0.96
53rd
0.62
30th
Cash ratio (cash + ST investments / current liabilities) 2.64
94th
0.46
66th
0.07
21st
Defensive interval (days) 774 days
79th
181 days
13th
553 days
66th

Leverage & solvency (latest quarter)

13 measures
MeasureTPLEXEPR
Total debt $15.5M
6th
$3.7B
72nd
$3.1B
66th
Debt / equity 0.01
4th
0.19
17th
0.26
26th
Net debt / equity −0.14
4th
0.12
17th
0.25
28th
Debt / assets 0.8%
4th
13.3%
15th
16.9%
28th
Debt / capital 0.9%
4th
16.1%
17th
20.7%
26th
Debt / EBITDA 0.02
5th
0.56
11th
0.84
32nd
Net debt / EBITDA −0.31
5th
0.36
14th
0.81
34th
Interest coverage (EBIT / interest) 345.2x
100th
17.0x
84th
6.2x
56th
Cash interest coverage 306.9x
100th
25.9x
80th
15.3x
61st
Debt payback (years of OCF) 0.0 yrs
7th
0.7 yrs
20th
0.8 yrs
24th
Liabilities / assets 10.1%
2nd
30.8%
13th
35.1%
19th
IS credit model rating AAA AA A+
Implied credit spread (bps) 50
0th
80
13th
125
26th

Efficiency

11 measures
MeasureTPLEXEPR
Asset turnover 0.55
91st
0.48
70th
0.32
30th
Fixed asset turnover 4.58
89th
0.55
59th
0.34
33rd
Inventory turnover — — —
Receivables turnover 6.2
13th
12.5
74th
12.3
72nd
Days sales outstanding 59 days
87th
29 days
26th
30 days
28th
Days inventory outstanding — — —
Days payables outstanding 488 days
98th
63 days
62nd
11 days
4th
Cash conversion cycle (days) −429 days
2nd
−33 days
34th
18 days
81st
Capex / revenue 8.5%
20th
23.2%
41st
0.9%
7th
Capex / depreciation 1.13
59th
1.06
52nd
0.02
7th
Operating expense ratio 10.6%
19th
56.2%
96th
30.1%
57th

Cash flow & earnings quality

7 measures
MeasureTPLEXEPR
Operating cash flow / net income 1.11
0th
2.03
44th
3.23
79th
FCF / net income 0.97
47th
0.91
44th
3.19
88th
FCF / operating cash flow 87.3%
86th
45.0%
50th
98.8%
93rd
Capex / operating cash flow 12.7%
13th
55.0%
51st
1.2%
7th
Accruals ratio -3.8%
91st
-10.3%
70th
-15.3%
36th
Sloan accruals ratio -21.0%
6th
-8.6%
60th
-11.9%
38th
Earnings quality score (0-1) 1.00
82nd
0.75
0th
0.75
0th

Dividends & buybacks

9 measures
MeasureTPLEXEPR
Dividend yield 0.7%
28th
2.5%
53rd
2.6%
55th
Dividend per share (TTM) $2.33
89th
$2.30
87th
$0.63
43rd
Payout ratio (dividends / net income) 29.0%
61st
27.5%
52nd
40.9%
73rd
Dividends / FCF 29.8%
64th
30.1%
67th
12.8%
33rd
Dividend growth (YoY) -57.4%
8th
57.2%
100th
-5.4%
39th
Buyback yield 0.0%
34th
2.7%
77th
0.1%
45th
Shareholder yield (dividends + buybacks) 0.7%
15th
6.2%
72nd
2.6%
30th
Share count change (YoY) -0.0%
40th
-0.9%
32nd
14.6%
79th
Buybacks, last 5 years $104.7M
51st
$1.0B
81st
$294.8M
62nd

Scores & forensic checks

15 measures
MeasureTPLEXEPR
IS score 81
91st
77
85th
76
83rd
IS profitability 100
96th
69
55th
76
68th
IS growth 71
70th
77
87th
55
46th
IS value 36
9th
87
85th
81
70th
IS momentum 88
57th
100
89th
83
48th
IS risk (safety) 100
91st
65
77th
50
62nd
IS quality 93
91st
89
85th
86
77th
IS balance sheet 88
96th
77
85th
63
64th
IS earnings quality 69
70th
71
77th
53
45th
IS cash flow 85
77th
74
66th
100
100th
Piotroski F-score (0-9) 7
43rd
9
96th
7
43rd
Altman Z-score 100.2
100th
2.7
79th
2.2
70th
Beneish M-score −0.56
87th
−7.07
4th
−2.23
71st
Ohlson O-score −16.27
2nd
−11.05
6th
−9.95
19th
IS credit score 97
94th
87
85th
75
70th

Per share

7 measures
MeasureTPLEXEPR
EPS, diluted (TTM) $7.84
89th
$11.67
94th
$1.44
36th
Book value per share $24.23
60th
$81.43
91st
$14.04
43rd
Tangible book per share $11.89
32nd
$81.48
91st
$14.34
40th
Revenue per share $13.00
47th
$56.09
91st
$6.71
28th
FCF per share $7.63
81st
$10.66
85th
$4.61
64th
Operating cash flow per share $8.74
57th
$23.68
89th
$4.67
38th
Cash per share $3.60
81st
$5.73
91st
$0.15
13th

Size (TTM)

8 measures
MeasureTPLEXEPR
Market cap $24.2B
85th
$21.6B
83rd
$20.6B
81st
Revenue $897.5M
36th
$13.4B
87th
$5.7B
77th
EBITDA $745.9M
51st
$6.6B
85th
$3.7B
81st
Net income $541.4M
62nd
$2.8B
87th
$1.2B
81st
Free cash flow $526.7M
66th
$2.5B
85th
$3.9B
89th
Total assets $1.9B
34th
$28.0B
85th
$18.5B
79th
Shareholders' equity $1.7B
40th
$19.4B
85th
$12.0B
83rd
Employees 114
21st
1,600
81st
515
55th

Price performance

9 measures
MeasureTPLEXEPR
1 day +1.3% +2.9% +4.3%
1 week −2.8% +5.9% +6.9%
1 month +1.1% +5.8% +6.1%
3 months −13.5% +7.4% +21.4%
6 months −16.9% −2.5% +26.8%
Year to date +17.9% −14.9% +71.0%
1 year −62.0% −9.0% +102.5%
3 years, cumulative −41.4% +12.6% +93.1%
5 years, cumulative −8.3% +75.1% +286.5%

Technicals

4 measures
MeasureTPLEXEPR
RSI 14 48.4 60.9 66.4
From 52-week high −66.5% −26.2% 0.0%
From 52-week low +25.1% +12.2% +108.8%
Beta 0.59 0.32 0.48
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms